Acute otitis media and its prevention by immunization: A survey of canadian paediatricians' knowledge, attitudes and beliefs

Human Vaccines

Volumn 7, Issue 4, 2011, Pages

  Dube, Eve ^a,c   Gilca, Vladimir ^a,c   Sauvageau, Chantal ^a,c   Bradet, Richard ^b   Lavoie, France ^b   Boulianne, Nicole ^a,c   Boucher, François D ^b   Bettinger, Julie A ^d,e   McNeil, Shelly ^f   Gemmill, Ian ^g  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BC CHILDREN S HOSPITAL   (Canada)

^f Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^g Kingston   (Canada)

Author keywords

Acute otitis media; Analytical framework for immunization programs; Attitudes; Beliefs; Health belief model; Knowledge; Paediatricians; Pneumococcal conjugate vaccines

Indexed keywords

ACUTE OTITIS MEDIA; ARTICLE; CANADA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH BELIEF MODEL; HUMAN; IMMUNIZATION; MALE; PEDIATRICIAN; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; HEALTH PERSONNEL ATTITUDE; IMMUNOLOGY; INFANT; NEWBORN; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PROFESSIONAL COMPETENCE; STATISTICS;

PNEUMOCOCCUS VACCINE;

ATTITUDE OF HEALTH PERSONNEL; CANADA; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROFESSIONAL COMPETENCE; QUESTIONNAIRES;

EID: 79955004391     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.4.14141     Document Type: Article

References (54)

1. O'Klein J, The burden of otitis media. Vaccine 2001; 19:2-8.
2. Casselbrant ML, Mandel EM. Epidemiology. In: Rosenfeld RM, Bluestone CD, editors. Evidence-based otitis media. Ontario: Decker 1999; 117-36.
3. Teele DW, Klein JO, Rosner BA, et al. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989; 160:83-94. (Pubitemid 19162997)
4. Casselbrant ML, Mandel EM. Epidemiology. In: Rosenfeld RM, Bluestone CD, editors. Evidence-based otitis media. Ontario: Decker 1999; 117-36.
5. Giebink GS. Prevention. In: Rosenfeld RM, Bluestone CD, Editors. Evidence-based otitis media. Ontario: Decker 1999; 223-34.
6. Petit G, De Wals P, Law B, Tam T, Erickson LJ, Guay M, et al. Epidemiological and economic burden of pneumococcal diseases in Canadian children. Can J Infect Dis 2003; 14:215-20. (Pubitemid 37295932)
7. Morrow A, De Wals P, Petit G, Guay M, Erickson LJ. The burden of pneumococcal disease in the canadian population before routine use of the seven-valent pneumococcal conjugate vaccine. Can J Infec Dis & Med Microb 2007; 18:121-7.
8. Asmussen L, Olson L, Sullivan SA. «You have to live it to understand it...» - Family Experiences with chronic otitis media in children. Ambulatory Child Health 1990; 5:303-12.
9. Boruk M, Lee P, Faynzilbert Y, Rosenfeld RM. Caregiver well-being and child quality of life. Otolaryngology - Head and Neck Surgery 2007; 146:159-68. (Pubitemid 46176227)
10. Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 2007; 26:97-106. (Pubitemid 46183358)
11. th edition Ottawa: Public Health Agency of Canada 2006; 7:372.
12. Public Health Agency of Canada, Immunization coverage against invasive pneumococcal disease among children in the capital health region of Alberta. Canada Communicable Disease Report 2005; 31-06.
13. Boulianne N, Audet D, Ouakki M, Guay M, Duval B, De Serres G. Enquête sur la couverture vaccinale des enfants québécois en 2006. Institut national de santé publique du Québec: Québec 2007; 104.
14. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95. (Pubitemid 30167436)
15. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403-9. (Pubitemid 32128672)
16. Ramani RR, Hall WN, Boulton M, Johnson DR, Zhu BP. Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study. Am J Public Health 2004; 94:958-9. (Pubitemid 38691539)
17. Wyeth Canada, Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197) Protein. Wyeth Canada: Montréal 2009; 44.
18. Prymula R, Peeters P, Chrobok V, Kriz P, Novakoya E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 4:740-8. (Pubitemid 43326292)
19. Dionne M, Boulianne N, Duval B, Lavoie F, Laflamme N, Carsley J, et al. Manque de conviction face à la vaccination chez certains vaccinateurs québécois. Rev can santé publique 2001; 92:100-4.
20. Persaude D, Teape-Humphrey L, Adelstein R, Domb S, Jaakkimainen L. Peril of the pox. Are primary care providers aware of varicella vaccination guidelines? Canadian Family Physician 2002; 48:316-23. (Pubitemid 34285545)
21. Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006; 118:2280-9. (Pubitemid 46397565)
22. Posfay-Barbe KM, Heininger U, Aebi C, Desgrandchamps D, Vaudaux B, Siegrist CA. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics 2005; 116:623-33.
23. Koepke CP, Vogel CA, Kohrt AE. Provider characteristics and behaviors as predictors of immunization coverage. Am J Prev Med 2001; 21:250-5. (Pubitemid 32999091)
24. Szilagyi PG, Rodewald LE, Humiston SG, Hager J, Roghmann KJ, Doane C, et al. Immunization pratices of pediatricians and family physicians in the United States. Pediatrics 1994; 94:517-23. (Pubitemid 24295034)
25. Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005; 23:2470-6.
26. CDC, Vaccine-Preventable Diseases: Improving Vaccination Coverage in Children, Adolsecents and Adults - A Report on Recommendations of the Task Force on Community Preventive Services. Morb Mortal Wkly Rep 1999; 48:1-15.
27. Douglas RG. Will a new vaccine be used? J Hum Virol 2000; 3:77-80.
28. Taylor JA, Darden PM, Brooks DA, Hendricks JW, Baker AE, Wasserman RC. Practitioner policies and beliefs and practice immunization rates: a study from Pediatric Research in Office Settings and the National Medical Association. Pediatrics 2002; 109:294-300. (Pubitemid 34126872)
29. Schmitt HJ, Booy R, Aston R, Van Damme P, Schumacher RF, Campins M, et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 2007; 5:11.
30. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Psychosocial aspects of vaccine acceptability. Vaccine 2006; 24:201-9.
31. Lagarde F, Summary of Public Opinion on Immunization in Canada. Public Health Agency of Canada 2005; 19.
32. Oram RJ, Daum RS, Seal JB, Lauderdale DS. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. JAMA 2001; 285:1874-9. (Pubitemid 32289155)
33. Freed GL, Bordley WC, Clarks SJ, Konrad TR. Reactions of pediatricians to a new centers for disease control recommendation for universal immunization of infants with hepatitis B vaccine. Pediatrics 1993; 91:699-702. (Pubitemid 23115727)
34. Raley JC, Followwill KA, Zimet GD, Ault KA. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004; 12:127-33. (Pubitemid 40093203)
35. Clark SJ, Cowan AE, Wortley PM. Influenza vaccination attitudes and practices among US registered nurses. Am J Infect Control 2009; 37:551-6.
36. Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals - a review of studies on attitudes and predictors. Vaccine 2009; 27:3935-44.
37. Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract 2003; 16:363-71.
38. Schaffer SJ, Szilagyi PG, Shone LP, Ambrose SJ, Dunn MK, Barth RD, et al. Physician perspectives regarding pneumococcal conjugate vaccine. Pediatrics 2002; 110:68.
39. Daley MF, Crane LA, Beaty BL, Barrow J, Pearson K, Stevenson JM, et al. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages. Ambul Pediatr 2005; 5:157-64.
40. Boulianne N, Bradet R, Audet D, Deceuninck G. Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2008. Institut national de santé publique du Québec: Québec 2009; 1-205.
41. CDC. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2008. MMWR Morb Mortal Wkly Rep 2008; 57:1148-51.
42. De Wals P, Robin E, Fortin E, Thibeault R, Ouakki M, Douville-Fradet M. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2008; 27:963-8.
43. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369:1179-86. (Pubitemid 46527876)
44. Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, et al. Vaccination against human papillomavirus: A baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007; 25:7841-7.
45. th International Papillomavirus Conference and Clinical Workshop, Beijing International Convention Center 2007; China.
46. Broder KR, MacNeil A, Malone S, Schwartz B, Baughman AL, Murphy TV, et al. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations. Pediatrics 2005; 115:1479-87.
47. Crane LA, Daley MF, Barrow J, Babbel C, Stokley S, Dickinson LM, et al. Sentinel physician networks as a technique for rapid immunization policy surveys. Eval Health Prof 2008; 31:43-64.
48. Victor JC, Brewster JM, Ferrence R, Ashley MJ, Cohen JE, Selby P. Tobacco-related medical education and physician interventions with parents who smoke: Survey of Canadian family physicians and pediatricians. Canadian Family Physician 2010; 56:157-63.
49. th International Papillomavirus Conference and Clinical Workshop, Beijing International Convention Center 2007; China.
50. Lavergne B, Frappier-Davignon L. Essai clinique de trivirix (R) pour l'immunisation contre la rougeole, les oreillons et la rubéole. RHMC 1986; 12:85-8.
51. Rosenstock IM. The health belief model: Explaining health behavior through expectancies, in Health behavior and health education - Theory research and practice. Glanz KL, Rimer BK, Editor. Jossey-Bass Publishers: San Francisco CA 1991; 39-62.
52. Public Health Agency of Canada, Canadian Human Papillomavirus Vaccine Research Priorities Workshop - Final Report. CCDR 2005; 32:66.
53. Comité sur l'immunisation du Québec, Évaluation de la pertinence d'un programme d'immunisation contre les infections pneumococciques chez l'enfant comportant un nombre réduit de doses de vaccin conjugué - Édition révisée. Institut national de santé publique du Québec: Québec 2005; 40.
54. Comité sur l'immunisation du Québec, Prévention par la vaccination des maladies attribuables aux virus du papillome humain. Institut national de santé publique du Québec: Québec 2007; 76.